What is the value and preference placed on RASi to prevent CV and CKD events?
In the opinion of the Work Group, this recommendation for people with diabetes and CKD with severely increased albuminuria places higher value on the ability of RASi to prevent CV and CKD events, such as doubling of serum creatinine and dialysis. It places less value on the risks of hyperkalemia and AKI.